Yoga therapy as an add‐on treatment in the management of patients with schizophrenia – a randomized controlled trial
- 22 May 2007
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 116 (3), 226-232
- https://doi.org/10.1111/j.1600-0447.2007.01032.x
Abstract
Objective: Treatment of schizophrenia has remained unsatisfactory despite the availability of antipsychotics. This study examined the efficacy of yoga therapy (YT) as an add‐on treatment to the ongoing antipsychotic treatment. Method: Sixty‐one moderately ill schizophrenia patients were randomly assigned to YT (n = 31) and physical exercise therapy (PT; n = 30) for 4 months. They were assessed at baseline and 4 months after the start of intervention, by a rater who was blind to their group status. Results: Forty‐one subjects (YT = 21; PT = 20) were available at the end of 4 months for assessment. Subjects in the YT group had significantly less psychopathology than those in the PT group at the end of 4 months. They also had significantly greater social and occupational functioning and quality of life. Conclusion: Both non‐pharmacological interventions contribute to reduction in symptoms, with YT having better efficacy.Keywords
This publication has 20 references indexed in Scilit:
- Negative symptoms of schizophrenia: a problem that will not go awayActa Psychiatrica Scandinavica, 2006
- A Brief but Comprehensive Lifestyle Education Program Based on Yoga Reduces Risk Factors for Cardiovascular Disease and Diabetes MellitusThe Journal of Alternative and Complementary Medicine, 2005
- Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugsActa Psychiatrica Scandinavica, 2004
- Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramineJournal of Affective Disorders, 2000
- Pathways to schizophrenia: the impact of environmental factorsInternational Journal of Neuropsychopharmacology, 1999
- Factors influencing relapse in the long-term course of schizophreniaSchizophrenia Research, 1997
- Diagnosis of Secondary Depression in Schizophrenia: Implications for DSM-IVSchizophrenia Bulletin, 1991
- Dysphoric and depressive symptoms in chronic schizophreniaSchizophrenia Research, 1989
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970